410 Medical

Executive Summary

410 Medical is a private medical device company based in Durham, NC, specializing in innovative solutions for hemorrhagic shock and fluid resuscitation. The company's technology aims to rapidly restore perfusion in critical care settings, as demonstrated in a late-2025 clinical case where their product was used to treat a 78-year-old patient with gastrointestinal bleed-induced hemorrhagic shock. Founded in 2013, 410 Medical operates within the Carolinas biotech ecosystem, targeting a large unmet need in emergency medicine. With a strong proof-of-concept case, the company is advancing its regulatory and clinical strategy to address the significant market for acute blood loss management. Key near-term catalysts include potential FDA clearance for expanded indications, publication of clinical outcomes, and strategic partnerships to scale distribution. The company's focused approach and early clinical traction position it for growth in the critical care device market.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Expanded Hemorrhagic Shock Indication70% success
• Q4 2026Publication of Clinical Case Series in Peer-Reviewed Journal85% success
• Q1 2027Strategic Partnership with Major Critical Care Distributor50% success